デフォルト表紙
市場調査レポート
商品コード
1485018

経皮パッチ市場- 世界の産業規模、シェア、動向、機会、予測、パッチタイプ別、粘着剤タイプ別、用途別、エンドユーザー別、地域別、競合別セグメント、2019-2029年

Transdermal Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patch Type, By Adhesive Type, By Application, By End-User, By Region and Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 186 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

経皮パッチ市場- 世界の産業規模、シェア、動向、機会、予測、パッチタイプ別、粘着剤タイプ別、用途別、エンドユーザー別、地域別、競合別セグメント、2019-2029年
出版日: 2024年05月24日
発行: TechSci Research
ページ情報: 英文 186 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

経皮パッチの世界市場規模は2023年に63億5,000万米ドルとなり、2029年までの予測期間のCAGRは4.53%で着実な成長が予測されています。

経皮パッチの世界市場は、従来の薬物投与形態に代わる非侵襲的で便利な代替手段を提供することで、大きな成長を遂げています。経皮パッチは、皮膚から薬剤を送達する粘着パッチで、治療薬を血流に制御して持続的に放出します。この市場の拡大は、慢性疾患の増加、疼痛管理ソリューションの需要、患者に優しいドラッグデリバリー方法の重視など、いくつかの要因によって推進されています。心血管疾患、糖尿病、慢性疼痛などの慢性疾患の増加が、長期間にわたって薬剤を安定的に放出し、患者のコンプライアンスを高めるため、経皮パッチの採用を促進しています。

市場概要
予測期間 2025-2029
市場規模:2023年 63億5,000万米ドル
市場規模:2029年 82億米ドル
CAGR:2024年~2029年 4.53%
急成長セグメント 病院・クリニック
最大市場 北米

パッチは薬物の血中濃度を一定に保つため、他のデリバリー方法に伴う変動や副作用を最小限に抑えることができます。経皮パッチに関連する利便性と使いやすさが、患者やヘルスケアプロバイダーの間で人気の要因となっています。パッチは頻繁な投与の必要性をなくし、胃腸障害のリスクを減らし、全体的な治療アドヒアランスを向上させます。マイクロニードルパッチやリアルタイムモニタリング用センサー付きスマートパッチなどのイノベーションを取り入れたパッチデザインの技術的進歩が、市場成長をさらに促進しています。世界市場情勢の拡大は、患者中心のヘルスケアソリューションへのシフトと、世界の製薬業界における効率的でユーザーフレンドリーなドラッグデリバリー方法への嗜好の高まりを示しています。

主な市場促進要因

慢性疾患の有病率の上昇

患者に優しいドラッグデリバリー

主な市場課題

皮膚透過性

限られた薬剤量

主な市場動向

治療用途の拡大

個別化医療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別(薬剤内包型、マトリックスパッチ、リザーバー膜パッチ、マイクロニードルパッチ、蒸気パッチ)
    • 粘着剤タイプ別(アクリル、シリコン、ハイドロゲル、その他)
    • 用途別(疼痛管理、ホルモン療法、中枢神経系疾患、心血管疾患、禁煙、その他)
    • エンドユーザー別(在宅ケア環境、病院、診療所)
    • 企業別(2023)
    • 地域別
  • 市場マップ

第6章 北米の経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別
    • 粘着剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別
    • 粘着剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別
    • 粘着剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別
    • 粘着剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの経皮パッチ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • パッチタイプ別
    • 粘着剤タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併および買収(該当する場合)
  • 製品の発売(ある場合)
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • AbbVie, Inc.
  • AdhexPharma SAS
  • Agile Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hamamatsu Pharma Research, Inc.
  • Endo, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 23930

Global Transdermal Patches Market was valued at USD 6.35 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.53% through 2029. The Global Transdermal Patches Market has witnessed significant growth, offering a non-invasive and convenient alternative to traditional forms of drug administration. Transdermal patches are adhesive patches that deliver medication through the skin, providing a controlled and sustained release of therapeutic agents into the bloodstream. This market's expansion is propelled by several factors, including the increasing prevalence of chronic diseases, the demand for pain management solutions, and the emphasis on patient-friendly drug delivery methods. The rise in chronic conditions, such as cardiovascular diseases, diabetes, and chronic pain, has driven the adoption of transdermal patches as they offer a consistent release of medication over an extended period, enhancing patient compliance.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 6.35 Billion
Market Size 2029USD 8.20 Billion
CAGR 2024-20294.53%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

These patches provide a steady blood concentration of the drug, minimizing fluctuations and side effects associated with other delivery methods. The convenience and ease of use associated with transdermal patches contribute to their popularity among patients and healthcare providers. The patches eliminate the need for frequent dosing, reduce the risk of gastrointestinal issues, and enhance overall treatment adherence. Technological advancements in patch design, incorporating innovations like microneedle patches and smart patches with sensors for real-time monitoring, further propel market growth. The expansion of the Global Transdermal Patches Market is indicative of a shift toward patient-centric healthcare solutions and a growing preference for efficient and user-friendly drug delivery methods in the global pharmaceutical landscape.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The Global Transdermal Patches Market is significantly influenced by the escalating prevalence of chronic diseases, a trend that underscores the importance of innovative and patient-friendly drug delivery methods. Chronic diseases, encompassing conditions such as cardiovascular disorders, diabetes, and chronic pain, have witnessed a substantial increase globally. This surge in prevalence is attributable to factors like aging populations, sedentary lifestyles, and dietary changes. Transdermal patches have emerged as a valuable solution in the management of chronic diseases due to their non-invasive nature and ability to provide controlled and sustained drug delivery. The rising incidence of conditions requiring long-term medication, such as hypertension and diabetes, has driven the demand for efficient and convenient drug administration methods. Transdermal patches offer a continuous release of medication through the skin, ensuring a steady blood concentration of the drug over an extended period.

One of the key advantages of transdermal patches in addressing chronic diseases is the enhancement of patient adherence. Managing chronic conditions often requires consistent medication adherence, and transdermal patches eliminate the need for frequent dosing, reducing the likelihood of missed doses. This is particularly crucial in diseases like diabetes, where maintaining stable blood glucose levels is paramount for effective management. The controlled release provided by transdermal patches contributes to minimizing fluctuations in drug levels, thereby reducing the risk of side effects commonly associated with other routes of administration. Patients with chronic conditions often require long-term therapy, and transdermal patches offer a practical and comfortable alternative, aligning with the evolving landscape of patient-centric healthcare. As the prevalence of chronic diseases continues to rise, the Global Transdermal Patches Market is poised for sustained growth. The versatility and convenience offered by transdermal patches position them as a vital component in the broader spectrum of healthcare solutions designed to address the complex challenges posed by the increasing burden of chronic conditions worldwide.

Patient-Friendly Drug Delivery

Patient-friendly drug delivery stands as a cornerstone of the Global Transdermal Patches Market, revolutionizing the way medications are administered and reinforcing the appeal of transdermal patches across diverse patient populations. This approach prioritizes convenience, ease of use, and improved patient adherence, addressing the challenges associated with traditional drug delivery methods. Transdermal patches offer a non-invasive and user-friendly alternative, eliminating the need for injections or frequent oral dosing. This shift is particularly significant for patients who may experience discomfort, inconvenience, or difficulty with other routes of administration, such as elderly individuals or those with certain medical conditions. The simplicity of application and the extended-release mechanism of transdermal patches contribute to enhanced patient adherence. Patients can apply the patch themselves, reducing the reliance on healthcare professionals for administration. This self-administration capability fosters a sense of empowerment and autonomy among patients, promoting a more active role in their treatment regimens. The patient-friendly nature of transdermal patches is particularly advantageous in chronic disease management.

Patients with conditions like hypertension, where consistent medication adherence is crucial for effective control, benefit from the continuous and controlled drug release provided by transdermal patches. The patches offer a steady blood concentration of the drug, minimizing the risk of missed doses and fluctuations in therapeutic levels. The convenience of transdermal patches aligns with the demands of modern healthcare, where personalized and patient-centric approaches are gaining prominence. The elimination of the need for frequent dosing simplifies treatment regimens, reduces the potential for medication errors, and improves overall patient satisfaction. As the Global Transdermal Patches Market continues to thrive, the patient-friendly attributes of these drug delivery systems position them as an integral component of the evolving landscape of healthcare. The emphasis on enhancing the patient's experience through convenient and accessible drug delivery methods contributes to the market's growth and underscores the importance of putting patients at the center of healthcare innovations.

Key Market Challenges

Skin Permeability

Skin permeability is a critical factor influencing the effectiveness and scope of the Global Transdermal Patches Market. The success of transdermal drug delivery hinges on the ability of therapeutic agents to permeate the skin barrier, facilitating their absorption into the bloodstream. While transdermal patches offer a non-invasive and convenient method for drug administration, the inherent properties of the skin present challenges that impact the range of drugs suitable for this delivery route. The skin, comprising the outermost layer called the stratum corneum, acts as a formidable barrier, preventing the easy passage of molecules. Skin permeability is influenced by various factors, including molecular size, lipophilicity, and the specific chemical characteristics of the drug. Small, lipophilic molecules generally have higher permeability, allowing for better absorption through the skin.

One challenge in the Global Transdermal Patches Market is posed by drugs with larger molecular sizes or hydrophilic properties, which may struggle to penetrate the skin effectively. Designing formulations that enhance the permeability of such drugs while maintaining safety and efficacy is a continual area of research and development. The variability in skin permeability among individuals further complicates transdermal drug delivery. Factors such as skin thickness, hydration levels, and overall skin health can impact drug absorption rates. This individual variability necessitates the development of transdermal patches that accommodate diverse patient characteristics, ensuring consistent and predictable drug delivery. Innovations in skin permeation enhancers, such as penetration enhancers or microneedle technologies, aim to overcome these challenges. These enhancers can temporarily modify the skin barrier, facilitating the penetration of drugs with suboptimal permeability. However, careful consideration must be given to the safety and long-term effects of these enhancers.

Limited Drug Payload

The concept of limited drug payload poses a notable challenge in the Global Transdermal Patches Market, influencing the selection of drugs suitable for transdermal delivery and shaping the design and formulation of these patches. Transdermal patches, while offering a convenient and non-invasive route for drug administration, are constrained by the finite amount of drug that can be incorporated into the patch. The limited drug payload is primarily due to practical considerations related to the size and thickness of the patch, as well as the need for patient comfort and wearability.

Transdermal patches are typically designed to be discreet, flexible, and conformable to the skin, making it challenging to accommodate large quantities of drug substances. This constraint restricts the application of transdermal patches to drugs requiring lower doses for therapeutic effectiveness. Medications with higher dosage requirements, especially those intended for conditions with a need for a substantial amount of active pharmaceutical ingredients, may exceed the payload capacity of transdermal patches. Addressing the limited drug payload challenge involves a delicate balance between optimizing the therapeutic dose, ensuring patient safety, and maintaining the practicality of patch design. Researchers and pharmaceutical companies working in transdermal space continually strive to develop formulations that maximize drug absorption while staying within the payload limits.

Key Market Trends

Expansion of Therapeutic Applications

The Global Transdermal Patches Market is experiencing a noteworthy trend in the expansion of therapeutic applications, marking a shift beyond traditional uses to encompass a broader range of medical conditions. While transdermal patches have long been associated with pain management and hormone replacement therapy, the market is witnessing a proliferation of patches designed for diverse therapeutic areas. One significant area of expansion is in cardiovascular diseases, where transdermal patches are increasingly utilized for the delivery of medications aimed at managing conditions like hypertension and angina. The convenience and sustained release provided by transdermal patches align well with the chronic nature of cardiovascular diseases, offering patients a non-invasive and continuous drug delivery option. Neurological disorders represent another frontier in the expanding therapeutic landscape of transdermal patches. Patches designed to deliver medications for conditions such as Parkinson's disease and Alzheimer's disease are gaining attention. The controlled and steady release of neuroactive drugs through the skin provides a potential advantage in managing these complex and chronic neurological conditions.

Transdermal patches are making inroads in diabetes management. Patches delivering insulin or other antidiabetic medications offer an alternative to injections, providing a more patient-friendly approach for individuals managing diabetes. This trend is particularly significant given the rising prevalence of diabetes globally and the need for effective and convenient treatment options. The expansion of therapeutic applications is not limited to chronic diseases; transdermal patches are also finding utility in acute care scenarios. Patches delivering antiemetic medications or analgesics for postoperative pain management are gaining traction, providing an additional tool for healthcare practitioners to optimize patient outcomes. Overall, the trend towards expanding therapeutic applications reflects the versatility and adaptability of transdermal patches in addressing a diverse array of medical conditions. As research and development efforts continue, the Global Transdermal Patches Market is poised to witness further diversification, with patches playing an increasingly vital role in delivering a wide range of medications across various therapeutic domains.

Personalized Medicine

The Global Transdermal Patches Market is aligning with the evolving paradigm of personalized medicine, contributing to a transformative approach in drug delivery. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, considering factors such as genetics, lifestyle, and the specific nature of their condition. In the context of transdermal patches, this trend is shaping the development of more precise and patient-specific therapeutic interventions. One key aspect of personalized medicine in the transdermal patches market is the customization of drug dosages based on individual patient's need. Rather than employing a one-size-fits-all approach, patches can be designed to deliver specific drug amounts that match the unique requirements of each patient. This individualization of drug delivery aims to optimize therapeutic outcomes while minimizing the risk of side effects or under-dosing.

Genetic variations among individuals influence drug metabolism and response. In the realm of personalized medicine, researchers are exploring the integration of genetic information to design transdermal patches that account for genetic factors affecting drug absorption, distribution, metabolism, and elimination. This approach allows for a more tailored and effective drug delivery, taking into consideration the genetic diversity observed among patients. Lifestyle factors and patient preferences play a crucial role in personalized medicine. Transdermal patches, being non-invasive and offering a convenient mode of drug administration, are well-suited to accommodate individual lifestyle choices. Patients may prefer patches over other delivery methods, such as injections or oral medications, contributing to improved treatment adherence. The integration of wearable technologies and digital health tools further enhances the personalization of transdermal patches. Smart patches equipped with sensors can monitor various physiological parameters, allowing real-time data collection. This data can be utilized to adjust drug delivery parameters, providing a dynamic and adaptive approach to personalized medicine. In conclusion, the Global Transdermal Patches Market is embracing personalized medicine principles, leveraging advancements in drug delivery technology to provide tailored and patient-centric solutions. As research and innovation progress, the synergy between transdermal patches and personalized medicine is expected to play a pivotal role in shaping the future of individualized healthcare.

Segmental Insights

Application Insights

Based on application, cardiovascular diseases segment dominated the Global Transdermal Patches Market in 2023. This is ascribed due to the prevalence of cardiovascular conditions and the need for targeted drug delivery. Transdermal patches provide a convenient and controlled release of medications, particularly for managing cardiovascular diseases like hypertension and angina. This patient-friendly approach enhances medication adherence and therapeutic outcomes. As cardiovascular diseases continue to rise globally, the demand for effective and non-invasive drug delivery methods escalates, making transdermal patches a preferred choice. The Cardiovascular Diseases segment's prominence is further fueled by the ongoing development of patch technologies tailored to address specific cardiac-related therapeutic needs.

End-User Insights

Based on end-user, hospitals & clinics segment emerged with a rapid growth in the Global Transdermal Patches Market in 2023. This is ascribed due to its central role as primary points of patient care and medication distribution. Hospitals & clinics are key in prescribing and administering transdermal patches, ensuring patient adherence and effective drug delivery. These healthcare settings benefit from the versatility and non-invasive nature of transdermal patches, making them suitable for various medical conditions. The segment's dominance is further reinforced by the widespread use of patches in managing chronic diseases, enhancing therapeutic outcomes. With a focus on comprehensive patient care, hospitals and clinics play a pivotal role in shaping the global landscape of transdermal patches.

Regional Insights

North America holds the largest segment in Global Transdermal Patches Market. This is ascribed due to well-established healthcare infrastructure, facilitating widespread adoption and accessibility of transdermal patches. The presence of major pharmaceutical companies and extensive research and development activities contribute to product innovation and market leadership. Stringent regulatory standards and a robust framework for product approvals enhance market confidence. Collectively, these factors position North America at the forefront, accounting for its dominant share in the global Transdermal Patches market.

Key Market Players

AbbVie, Inc.

AdhexPharma SAS

Agile Therapeutics, Inc.

Boehringer Ingelheim International GmbH

Corium, Inc.

GlaxoSmithKline PLC

Johnson & Johnson Services, Inc.

Novartis AG

Hamamatsu Pharma Research, Inc.

Endo, Inc.

Report Scope:

In this report, the Global Transdermal Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transdermal Patches Market, By Patch Type:

    Drug-In-Adhesive Matrix Patches Reservoir Membrane Patches Microneedle Patches Vapour Patches

Transdermal Patches Market, By Adhesive Type:

    Acrylic Silicone Hydrogel Other

Transdermal Patches Market, By Application:

    Pain Management Hormonal Application Central Nervous System Disorders Cardiovascular Diseases Smoking Cessation Other

Transdermal Patches Market, By End-User:

    Homecare Settings Hospitals & Clinics

Transdermal Patches Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transdermal Patches Market.

Available Customizations:

Global Transdermal Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Transdermal Patches Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Patch Type (Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Vapour Patches)
    • 5.2.2. By Adhesive Type (Acrylic, Silicone, Hydrogel, Other)
    • 5.2.3. By Application (Pain Management, Hormonal Application, Central Nervous System Disorders, Cardiovascular Diseases, Smoking Cessation, Other)
    • 5.2.4. By End-User (Homecare Settings, Hospitals & Clinics)
    • 5.2.5. By Company (2023)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Transdermal Patches Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Patch Type
    • 6.2.2. By Adhesive Type
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Transdermal Patches Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Patch Type
        • 6.3.1.2.2. By Adhesive Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Mexico Transdermal Patches Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Patch Type
        • 6.3.2.2.2. By Adhesive Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Canada Transdermal Patches Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Patch Type
        • 6.3.3.2.2. By Adhesive Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Transdermal Patches Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Patch Type
    • 7.2.2. By Adhesive Type
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Transdermal Patches Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Patch Type
        • 7.3.1.2.2. By Adhesive Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany Transdermal Patches Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Patch Type
        • 7.3.2.2.2. By Adhesive Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Transdermal Patches Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Patch Type
        • 7.3.3.2.2. By Adhesive Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Transdermal Patches Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Patch Type
        • 7.3.4.2.2. By Adhesive Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Transdermal Patches Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Patch Type
        • 7.3.5.2.2. By Adhesive Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia-Pacific Transdermal Patches Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Patch Type
    • 8.2.2. By Adhesive Type
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Transdermal Patches Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Patch Type
        • 8.3.1.2.2. By Adhesive Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Transdermal Patches Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Patch Type
        • 8.3.2.2.2. By Adhesive Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. South Korea Transdermal Patches Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Patch Type
        • 8.3.3.2.2. By Adhesive Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. Japan Transdermal Patches Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Patch Type
        • 8.3.4.2.2. By Adhesive Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Transdermal Patches Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Patch Type
        • 8.3.5.2.2. By Adhesive Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. South America Transdermal Patches Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Patch Type
    • 9.2.2. By Adhesive Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Transdermal Patches Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Patch Type
        • 9.3.1.2.2. By Adhesive Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina Transdermal Patches Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Patch Type
        • 9.3.2.2.2. By Adhesive Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia Transdermal Patches Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Patch Type
        • 9.3.3.2.2. By Adhesive Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. Middle East and Africa Transdermal Patches Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Patch Type
    • 10.2.2. By Adhesive Type
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Transdermal Patches Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Patch Type
        • 10.3.1.2.2. By Adhesive Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia Transdermal Patches Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Patch Type
        • 10.3.2.2.2. By Adhesive Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE Transdermal Patches Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Patch Type
        • 10.3.3.2.2. By Adhesive Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User
    • 10.3.4. Egypt Transdermal Patches Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Patch Type
        • 10.3.4.2.2. By Adhesive Type
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. AbbVie, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. AdhexPharma SAS
  • 14.3. Agile Therapeutics, Inc.
  • 14.4. Boehringer Ingelheim International GmbH
  • 14.5. Corium, Inc.
  • 14.6. GlaxoSmithKline PLC
  • 14.7. Johnson & Johnson Services, Inc.
  • 14.8. Novartis AG
  • 14.9. Hamamatsu Pharma Research, Inc.
  • 14.10. Endo, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer